Skip to main content
Clinical Trials/NCT01282359
NCT01282359
Completed
Phase 4

Efficacy of a Minimal Intervention Educational Program in the Asthma Control and Exacerbations Prevention

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 site in 1 country250 target enrollmentOctober 2011
ConditionsAsthma

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Asthma
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment
250
Locations
1
Primary Endpoint
Number of asthma exacerbations
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The asthma clinical practice guidelines categorize with the highest evidence level the effectiveness of educational programs. However, health care professionals not regularly applied it. This may contribute to inadequate control of the disease. Consequently, their designs and implementation strategies should be reviewed.

Hypothesis. An asthma educational program based on a limited intervention, managed by professionals with minimal training in education, could provide a significant decrease in the morbidity of the disease.

Objective. Determine the effectiveness, in terms of prevention of exacerbations (future risk) and improved asthma control (current control) of an educational program based on a reduced or minimal intervention.

Detailed Description

Method. A prospective, multicentre, centre randomized ("clusters analysis"), controlled, designed to evaluate the efficacy (reduction of exacerbations) and control degree control (increased ACT score) of an asthma educational program based on a limited intervention in patients with mild to moderate persistent asthma with an ACT \<20. The cases included will be distributed into three arms: the intervention group, who will take the limited educational asthma program; clinical practice group, who will not receive any specific education; and education "gold standard" group, which will receive a formal program of structured and individualized education. 250 cases will be including from 25 Spanish centres (pulmonary and primary care): 10 allocated to the intervention group, 10 clinical practice group, and 5 of the gold standard group. Each centre will enrol 10 patients and will be followed for a year in four programmed visits. At baseline and at follow-up visits, will be collected in each patient: ACT score, the number of emergency room visits, unscheduled visits, hospital admissions, cycles of oral prednisone (\> 15 days), compliance level, spirometric values and daily dose of inhaled corticosteroid (microg. or equivalent per day). Patients in the intervention group will receive the limited educational asthma program, which have three parts: basic information, establishment and revision of a small Action Plan (MiniPlan) and training and review of the inhalation skill of the prescribed device. Educators involved will attend a short workshop (6 h), where they will be trained in the program.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
September 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male and female asthma patients with mild or moderate persistent asthma after treatment according to criteria of the GINA
  • Aged 18 and under 70 years.
  • With ACT (Asthma Control Test) \<20 treated at the outpatient clinics of the participating centers.

Exclusion Criteria

  • Severe exacerbation of asthma (which required emergency room visit and/or hospitalization) within 30 days prior to visit
  • Severe disabling comorbidity.

Outcomes

Primary Outcomes

Number of asthma exacerbations

Time Frame: 1 year

Patients will be followed for a year in four programmed visits. At baseline and at follow-up visits, will be collected in each patient the number of asthma exacerbations.

Secondary Outcomes

  • ACT score(1 year)

Study Sites (1)

Loading locations...

Similar Trials